Evaluation of Possible Side Effects in the Treatment of Urinary Incontinence with Magnetic Stimulation

Pavčnik, Maja; Antić, Anja; Lukanović, Adolf; Krpan, Žan; Lukanović, David

doi:10.3390/medicina59071286

Cited by 2 publications

(1 citation statement)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the contrary, MS is a first-line non-invasive, standardizable, and with no adverse effects treatment for OAB [67]. Specifically, FMS is the newest innovation in MS technology.…”

Section: Discussionmentioning

confidence: 99%

Flat Magnetic Stimulation for Urge Urinary Incontinence

Barba,

Cola,

Rezzan

et al. 2023

Medicina

View full text Add to dashboard Cite

Background and Objectives: Strategies for overactive bladder syndrome (OAB) management involve, among others, strengthening the bladder outlet to suppress urgency and neuromodulating the sacral roots. Magnetic stimulation (MS) is a technology that involves an extracorporeal device that is able to provide an electromagnetic field specifically designed to interact with pelvic floor neuromuscular tissue. The resulting tissue electrical activity induces contraction of the pelvic muscle and neuromodulation of the S2–S4 sacral roots. Flat Magnetic Stimulation (FMS) is a relevant advancement involving homogeneous electromagnetic fields, which are able to optimize the effect on the entire pelvic area. However, the benefits of this new technology for OAB syndrome are poorly known. Consequently, the aim of our study is to analyze the outcomes and quality of life (QoL) impact of FMS with Dr. Arnold (DEKA, Calenzano, Italy) in women suffering from OAB syndrome associated with urinary incontinence. Materials and Methods: This prospective study included patients with OAB, urge urinary incontinence, and no ongoing OAB treatments. At baseline (T0), the Incontinence Impact Questionnaire (IIQ-7), the Female Sexual Function Index (FSFI-19), and the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form (ICIQ-UI SF) were collected. Patients underwent 8 FMS sessions of 25 min each in one month. At the termination of the therapy (T1), women repeated the ICIQ-UI SF, FSFI-19, and IIQ-7 tools. Moreover, the Patient Global Impression of Improvement (PGI-I) questionnaire was collected to evaluate the cure rate. Results: Our study enrolled a total of 57 consecutive patients. Most women had at least one second- or third-line treatment before FMS, while the remaining naive patients had contraindications to pharmacological treatments. No women reported adverse effects during the treatment. After the treatment, we observed a decrease in the IIQ-7 (p < 0.001) and ICIQ-UI SF scores (p < 0.001) and an improvement in sexual function (p < 0.001) evaluated with FSFI-19. According to PGI-I scores, 42 (73.7%) women referred to some kind of improvement, scoring ≤ 3 points. Specifically, 8.7% of patients considered themselves very much improved, 29.8% much improved, 35.1% minimally improved, and 26.3% found no changes. FMS was effective in treating OAB symptoms without any adverse effects. The mechanism is supposed to be related to suppressing the initiation of micturition. This makes FMS a promising device for treating naive and refractory urge urinary incontinence. Conclusions: The new FMS represents a promising non-pharmacological option for the treatment of naive and refractory OAB.

show abstract

“…On the contrary, MS is a first-line non-invasive, standardizable, and with no adverse effects treatment for OAB [67]. Specifically, FMS is the newest innovation in MS technology.…”

Section: Discussionmentioning

confidence: 99%

Flat Magnetic Stimulation for Urge Urinary Incontinence

Barba,

Cola,

Rezzan

et al. 2023

Medicina

View full text Add to dashboard Cite

show abstract

Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?

Tosun,

Akınsal,

Sönmez

et al. 2024

TCRM

View full text Add to dashboard Cite

Purpose To assess the effectiveness and safety of high-intensity focused electromagnetic technology (HIFEM) used as a therapeutic approach in patients with stress and mixed urinary incontinence. Patients and Methods Thirty-five females suffering from stress and mixed urinary incontinence were included in the study. The electromagnetic chair (BTL EMSELLA ® ) was applied to the patient’s pelvic area twice a week for 28 minutes, totaling 6 sessions. The patients’ “International Consultation on Incontinence Questionnaire‐Short Form” (ICIQ-SF) scores and the number of daily absorbent pad usage were recorded. Results were evaluated after the sixth session and at a first-month follow-up. Results The average ICIQ‐SF score at baseline was 10.18 ± 4.19 (ranging from 2–18) which declined to 5.33 ± 3.97 after six sessions, and further improved to 4.26 ± 3.94 points at the one‐month follow‐up. After six sessions, an average improvement of 52.06% in ICIQ-SF score was observed, and after one month of follow-up, an average improvement of 59.6% was detected, which was found to be statistically significant (p=0.038). In addition, the mean number of pads used per day decreased to 1.25 ± 1.54 after treatment, a significant improvement was observed, and the mean daily pad use decreased further to 0.91 ± 1.11 at the first-month follow-up. Conclusion HIFEM has demonstrated in our study its ability to safely and effectively treat female patients suffering from stress and mixed urinary incontinence, as evidenced by significant improvements in symptoms and quality of life observed in clinical trials.

show abstract

Evaluation of Possible Side Effects in the Treatment of Urinary Incontinence with Magnetic Stimulation

Cited by 2 publications

References 60 publications

Flat Magnetic Stimulation for Urge Urinary Incontinence

Flat Magnetic Stimulation for Urge Urinary Incontinence

Is the High-Intensity Focused Electromagnetic Energy an Effective Treatment for Urinary Incontinence in Women?

Contact Info

Product

Resources

About